OOIR: Observatory of International Research

Papers

(The TQCC of International Clinical Psychopharmacology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?	39
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia	30
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?	21
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge	20
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder	18
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?	17
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis	16
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure	16
Clinical specificity profile for novel rapid acting antidepressant drugs	16
Open issues in bipolar and antipsychotic treatments	14
Managing depression in the elderly: real-world clinical considerations and perspectives	14
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case	13
Assessing treatment adherence in psychiatry: a comparison of clinical judgment and therapeutic drug monitoring in acute care	13
Preliminary evidence that blood extracellular nicotinamide phosphoribosyltransferase increases with antidepressant response to chronotherapeutics and to monoaminergic drugs	13
Dropped-Head syndrome: a possible new variant of clozapine-induced inflammation during titration	12
Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.)	12
Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition	12
Persistence of suicidal ideation within acute phase treatment of major depressive disorder: analysis of clinical predictors	12
Antipsychotic polypharmacy in Japanese outpatients with schizophrenia: prevalence and sex- and age-related patterns	12
Remission of treatment-resistant obsessive-compulsive disorder with 600 milligrams of fluvoxamine daily: a case report	11
Debated issues in major psychoses	11
Towards a replicable protocol to identify patients with psychiatric disorders at higher risk of developing dementia	11
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials	10
Addressing the challenge of treatment adherence in major depressive disorder in different settings	10
Suicide in prison in the North of Italy (1993–2022): a case-control study examining differences between suicides inside and outside prison	10

The Gordian knot of the immune-redox systems’ interactions in psychosis	10
Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder	10
Transcranial direct current stimulation and cognitive modifiability in obsessive compulsive disorder: a reaction to recent findings by Pellegrini et al.	10
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder	10
Differentiating aspects of oral and long-acting injectable antipsychotic drugs for tailoring the therapy of schizophrenia in clinical practice: a narrative review	9
Elevated liver transaminases among patients with psychiatric disorders	9
Modulating factors in mood disorders treatment	9
Suicide behind bars: time to tackle barriers to mental healthcare access in prisons	9
Prevalence and correlates of prescription drug abuse and misuse among adult prisoners: a systematic review	9
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?	9
Navigating the pharmacologic complexities of QTc prolongation: assessing the cumulative burden in individuals with serious mental illness	8
Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia	8
Case report and systematic review of cerebellar vermis alterations in psychosis	8
Immediate-release vs. prolonged-release lithium formulations in bipolar disorder: a 2-year comparative study	8
Innovation in psychopharmacology	8
Manic episode in a patient with pancreatic adenocarcinoma: a case report	8
Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series	8
Cariprazine: an augmentation strategy for treatment-resistant schizophrenia with pro-cognitive and anti-hostility effects	8
The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results	8
Advances in the treatment of depression	7
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study	7
The challenge of managing difficult to treat psychiatric conditions	7
Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report	7
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial	7
The relationship between mobile phone addiction and depression, anxiety, and sleep quality in medical students	7
Interplay of environmental and clinical factors in psychiatric disorders	7
Treatment adherence in forensic patients with schizophrenia spectrum disorders discharged on long-acting injectable antipsychotics: a comparative 3-year mirror-image study	7
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?	7
Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience	7
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy	6
The effect of crocin versus sertraline in treatment of mild to moderate postpartum depression: a double-blind, randomized clinical trial	6
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?	6
Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation	6
Innovative pharmacotherapy for mood disorders: safety, cardiometabolic burden, and real-world implementation	6
Unspoken needs: an essential perspective in the treatment of schizophrenia	6
The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence	6
Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis	6
Differentiating the third generation of antipsychotics: a focus on lumateperone’s similarities and differences	6
Persian translation and validation of community attitudes toward the mentally ill scale: a tool for assessing social stigma about mental illness	6
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features	6
From cognitive endpoints to clinical reality in schizophrenia: antipsychotic choice, adherence, and functional outcomes	6